Amgen GmbH
Biotechnology, Medical Technology
-
Short facts
-
- Manufacturer
- Year founded 1989
- 315 Employees (site)
- Turnover: 50m <125m EUR
Products/services: Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses.
Basic data
Company
Amgen GmbH
Street
Riesstraße 24
PC / City
80992 München
County
Upper Bavaria
Phone
+49 89 149096-0
Fax
+49 89 149096-2000
Homepage
Language skills
English, German
Profile/competences
Core competencies
Amgen's corporate mission is to be the world leader in developing and delivering important, cost-effective therapeutics based on cellular and molecular biology. The company's first product, EPOGEN® (Epoetin alfa), stimulates and regulates the production of red blood cells. Amgen's second product, NEUPOGEN® (Filgrastim), is a recombinant granulocyte colony-stimulating factor (G-CSF) that selectively stimulates growth of infection-fighting white blood cells known as neutrophils. In 2001 Amgen launched a new drug, called Aranesp®, which also stimulates the production of red blood cells. Aranesp® was created by rational drug design and has a threefold longer halflife time compared to Epogen®. In 2002 AMGEN launched a second generation G-CSF called Neulasta® which also stimulates the growth of neutrophils. Neulasta® has an important advantage. Due to its pegylation Neulasta® has a longer half-life time and therefore has to be administered only once per chemotherapy cycle whereas Neupogen® has to be administered daily.
Key sectors / sub-sectors
- Biotechnology: Molecular diagnostics for humans
- Biotechnology: Therapeutic drug development
- Medical Technology: Technical services for medical technology
NACE industries
- Wholesale of chemical products 46.75
Certifications
not available
Sales markets - target industries
not available
Sales markets - target countries
not available
Cooperation offers
not available